Aroa Biosurgery (Australia) Today
| ARX Stock | 0.48 0.01 2.04% |
PerformanceVery Weak
| Odds Of DistressLow
|
Aroa Biosurgery is selling for under 0.48 as of the 14th of March 2025; that is 2.04 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.48. Aroa Biosurgery has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of December 2024 and ending today, the 14th of March 2025. Click here to learn more.
Business Domain Materials | Category Healthcare |
Aroa Biosurgery is entity of Australia. It is traded as Stock on AU exchange. The company has 345.93 M outstanding shares. More on Aroa Biosurgery
Moving together with Aroa Stock
Moving against Aroa Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aroa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aroa Biosurgery's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aroa Biosurgery or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Founder | MBA BVSc | ||||
| Business Concentration | Metals & Mining, Medical Devices, Healthcare, Materials, Metals & Mining, Medical Devices, Healthcare (View all Sectors) | ||||
Aroa Biosurgery's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aroa Biosurgery's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAroa Biosurgery can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aroa Biosurgery's financial leverage. It provides some insight into what part of Aroa Biosurgery's total assets is financed by creditors.
| |||||
Aroa Biosurgery (ARX) is traded on Australian Securities Exchange in Australia and employs 9 people. Aroa Biosurgery is listed under Metals & Mining category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 172.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aroa Biosurgery's market, we take the total number of its shares issued and multiply it by Aroa Biosurgery's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aroa Biosurgery operates under Metals & Mining sector and is part of Materials industry. The entity has 345.93 M outstanding shares.
Aroa Biosurgery generates negative cash flow from operations
Check Aroa Biosurgery Probability Of Bankruptcy
Ownership AllocationAroa Biosurgery holds a total of 345.93 Million outstanding shares. Aroa Biosurgery retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aroa Ownership Details
Aroa Biosurgery Risk Profiles
Although Aroa Biosurgery's alpha and beta are two of the key measurements used to evaluate Aroa Biosurgery's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.59 | |||
| Standard Deviation | 4.09 | |||
| Variance | 16.69 | |||
| Risk Adjusted Performance | (0.08) |
Aroa Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aroa Biosurgery without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Aroa Biosurgery Corporate Management
Elected by the shareholders, the Aroa Biosurgery's board of directors comprises two types of representatives: Aroa Biosurgery inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aroa. The board's role is to monitor Aroa Biosurgery's management team and ensure that shareholders' interests are well served. Aroa Biosurgery's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aroa Biosurgery's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neetha AlexKumar | General Counsel | Profile | |
| Barnaby May | Chief Officer | Profile | |
| Yasmin BSc | Regulatory Quality | Profile | |
| Brian Ward | CEO, Founder | Profile | |
| Adam Young | Vice Affairs | Profile |
Additional Tools for Aroa Stock Analysis
When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.